ABSCIENCES (EPA:AB) AB Science announced that it has received new authorizations to resume patient enrollment in its Phase 3 studies of masitinib

Transparency directive : regulatory news

14/09/2021 18:01


Other stories

23/09/2021 01:28
23/09/2021 07:51
23/09/2021 05:37
22/09/2021 23:29
23/09/2021 06:00
23/09/2021 00:40
22/09/2021 21:54
23/09/2021 02:08
22/09/2021 17:47
22/09/2021 21:37
22/09/2021 16:01
23/09/2021 03:14
22/09/2021 21:51
22/09/2021 23:52
23/09/2021 01:55
23/09/2021 08:02
22/09/2021 19:13
22/09/2021 20:01
22/09/2021 18:01
22/09/2021 15:00
21/09/2021 22:18
22/09/2021 23:30
22/09/2021 22:00
23/09/2021 03:19
22/09/2021 23:56
23/09/2021 02:45
23/09/2021 07:00
23/09/2021 07:03
23/09/2021 07:09
22/09/2021 23:19
22/09/2021 17:00
23/09/2021 05:30
21/09/2021 13:22
21/09/2021 12:07
22/09/2021 18:48
23/09/2021 01:01
22/09/2021 19:01
23/09/2021 05:37